This week hosts Mark Masselli and Margaret Flinter speak with renowned virus expert Dr. William Haseltine who has ‘grave concerns’ about Merck’s oral COVID drug Malnupiravir, which recently won narrow approval from the FDA advisory panel. He says the drug unleashes ‘dangerous’ mutations that could evolve the virus beyond control. He’s also urging extreme caution as the highly infectious omicron variant is sweeping across the US, saying it could be as deadly as the delta variant and that boosters may offer only limited protection of 3 months. Dr Haseltine, who developed the Anthrax vaccine and is President of ACCESS Health International, says public health protocols of masking, rapid testing and social distancing should be put back in place during this next surge.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
The new Rural Health Transformation Program aims to improve “healthcare access, quality, and outcomes” with…
New research. New technology. New possibilities. On this special 2025 Rewind and Look Ahead episode…
Health care policy faced major upheavals during the past 12 months and the effects are…
Eighty percent of maternal deaths in the United States are considered preventable. So why do…
Originally broadcast December 11, 2025 Congress is scrambling to find a solution to the enhanced…
Originally broadcast December 4, 2025 The doctor who once led the Centers for Disease Control…